Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery

Status unconfirmed · Not applicable

Conditions studied: Congenital Heart Disease

In brief

To evaluate if there is any clinical difference in patients 3.5-12kg who undergo cardiac surgery with cardiopulmonary bypass that do and do not receive blood products as part of their procedure. The main hypothesis of the study is that the patients undergoing bloodless cardiac surgery will have decreased morbidity and mortality when compared to the cohort that did receive blood as well as a shorter ICU and hospital length of stay.

Key facts

Study ID

NCT05881564

Run by

Augusta University

People needed

150

Starts

2023-05-10

Expected to finish

2026-05-12

Last updated by the study team

2023-06-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient weight 3.5-12kg
• Elective and urgent cardiac surgery with cardiopulmonary bypass
• Cases within the STS STAT categories of 1-4

You may not qualify if…

• Patients who weigh more than 12kg or less than 3.5kg.
• Patients undergoing emergency surgery.
• STAT category 5 cases.
• Patients whose surgery does not require cardiopulmonary bypass.
• Patients presenting preoperatively in shock.
• Patients with known blood dyscrasias.

Where it is running

• Children's Hospital of Georgia — Augusta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.